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What do chickens, human skin, subway trains and
bacteriophage have in common? This unlikely cast of
players sets the stage upon which the model that telomere
length signals cellular senescence was built. Two recent
papers provide evidence that telomere shortening in
human cells does indeed signal cells to enter ‘senescence’
[1,2]. I shall examine the development of the hypothesis,
the recent evidence supporting it, and its implications.
The cells
In 1908, Alexis Carrel, a Nobel prize-winning surgeon,
became interested in the growth of cells in culture. In
1912, he established a culture of chick heart fibroblast
cells, which he then grew in the laboratory for 34 years.
This work led to the general acceptance of the notion that
vertebrate cells can divide indefinitely in culture. As indi-
vidual cells were immortal, Carrel reasoned that aging is
“an attribute of the multicellular body as a whole”
(reviewed in [3]).
In 1961, this concept of cell immortality was challenged
by experiments published by Hayflick and Moorehead
[4]. They found that fibroblast cultures derived from
human skin would divide 40 to 50 times, and then stop
and “undergo senescence”. Further work showed that
cells from older people underwent fewer divisions than
cells from younger people, suggesting that it was the total
number of divisions since birth, not total divisions in
culture, that was important [5]. 
When subsequent work showed that Carrel’s immortal
chicken cell cultures were not reproducible, Hayflick’s
senescence model eventually became accepted (reviewed
in [3]). Two important questions emerged from the
nascent field of cellular senescence. First, what is the role
of cellular senescence in humans? Does the limited
capacity of cells to divide relate to human aging, or is it a
mechanism to prevent tumor formation (reviewed in [6])?
And second, what tells cells to stop dividing?
The phage and the train
In 1972, James D. Watson was preparing his lecture for the
biochemistry course at Harvard. In thinking about the
observation that bacteriophage T7 occurs in Escherichia coli
as long concatemers, Watson recognized that the end-to-
end joining of individual genomes could allow the com-
plete replication of the linear bacteriophage genome (J. D.
Watson, personal communication). Watson knew that
DNA polymerases act in the 5′ to 3′ direction and require
an RNA primer. He recognized that, when the polymerase
reached the end of a linear DNA molecule, there would
be a problem in completing replication. Linear phage
genomes can avoid this ‘end replication problem’ by
joining multiple genomes before replication, reducing the
number of actual ends and thus minimizing the damage
by incomplete replication [7].
Far away from Harvard at the Gamelaya Institute in the
then Soviet Union, Alexei Olovnikov was also thinking
about DNA molecules – while waiting for a subway train
[8]. When he heard the train approaching, he suddenly
saw a parallel with DNA replication. If the train engine
were replicating the DNA track, the first bit of DNA
would not be replicated as it would be underneath the
engine [8]. Interestingly, although both models recog-
nized a problem with DNA ends, Olovnikov’s model
predicted a problem at the beginning of DNA replication,
whereas Watson’s predicted a problem at the end.
Olovnikov knew of Hayflick’s work on cellular senescence
and recognized that the end replication problem might
trigger the Hayflick limit — too much chromosome
shortening might cause cellular senescence [9].
The telomere
In 1978, Blackburn, working in Gall’s laboratory at Yale,
was interested in determining the DNA sequence that
allowed the Tetrahymena rDNA molecule to be main-
tained as a linear chromosome. Her work led to the
finding that chromosome ends, or telomeres, are made of
simple repeated DNA sequences [10]. It soon became
apparent that this motif was conserved throughout evolu-
tion and that a common mechanism might exist in eukary-
otes for the maintenance of telomeres. In 1984, working
in Blackburn’s laboratory, I identified an enzyme, telom-
erase, that added telomere repeats onto chromosome
ends. We suggested that telomerase would compensate
for the incomplete replication of chromosome ends. This
would explain the telomere length maintenance seen in
organisms such as Tetrahymena and yeast [11]. Telomerase
is an unusual polymerase; it contains an integral RNA
component that provides the template for synthesis of
telomere repeats [12].
The connection
Insight into the molecular structure of the ends of human
chromosomes came from using a probe representing a
sequence on the Y chromosome that was near enough to
the telomere to follow the terminal chromosome fragment.
Using this probe, Cooke found that telomeres in germline
tissue (sperm) were longer than telomeres in somatic
tissue (blood cells). He speculated that telomere length is
tissue-specific and that telomere length shortens between
germline and somatic tissues [13]. Subsequently, the iden-
tification of the simple-sequence telomere repeat from
human cells [14] allowed a simple analysis of telomere
length and cell senescence. Harley, Futcher, and I then
found that telomeres indeed shorten as normal human
fibroblasts grow in culture [15]. Telomeres were also
shorter in skin samples from older people than from
younger people, suggesting that the shortening was not a
tissue culture phenomenon [15,16]. At about the same
time, Hastie et al. [16] and de Lange et al. [17] found that
tumor samples had shorter telomeres than adjacent normal
tissue, providing the first suggestion of a connection
between telomeres and cancer.
The synthesis
In the early 1990s, a model emerged which had two parts:
one that related telomeres to cell senescence, and the other
that linked telomeres, telomerase and cancer (reviewed in
[18]; Figure 1). The model stated that telomeres shorten
during growth of primary fibroblasts, because of the end
replication problem and the absence of telomerase.
Germline cells, in contrast, have telomerase and thus main-
tain telomere length. Telomere shortening signals cells to
senesce. Senescence, however, can be bypassed by expres-
sion of viral oncogenes. During this extended life span,
telomeres continue to shorten until the cell culture reaches
a crisis. At crisis many cells die. The few cells that survive,
can divide indefinitely. These cells have activated telom-
erase and maintain or even elongate telomeres. With the
demonstration that tumor cells, like immortal cells in
culture, express the enzyme, telomerase was proposed as a
potential target for anti-cancer therapy [15]. The recent
reports by Bodner et al. [1] and Vaziri and Benchimol [2]
provide strong evidence for the first part of this hypothesis
— that telomere shortening is a mechanism that limits cell
division capacity.
The experiment
To test whether telomere length signals cell senescence,
several groups have sought to elongate telomeres artifi-
cially and determine whether cellular life-span would be
extended. The recent isolation of the catalytic component
of telomerase allowed telomere length to be altered in
human cells. The catalytic component of Euplotes telom-
erase was isolated by Lingner in Cech’s laboratory [19],
and the sequence of the 123 kDa protein was shown to be
similar to Est2p of budding yeast, which is required for
telomere maintenance [20]. The homology of p123 and
Est2p to reverse transcriptase motifs allowed the elegant
demonstration that these proteins represent the catalytic
subunits of telomerase [21]. When a human cDNA frag-
ment encoding a protein sequence similar to p123 was
deposited in Genbank, several groups quickly cloned the
corresponding gene, hTERT [22–25] and showed that it
encodes an essential component of human telomerase
[24,26]. This set the stage for testing the role of telomeres
in cell senescence by forcing telomerase expression in
primary human cells.
The cloning of hTERT prompted a flurry of experiments
that resulted in a number of remarkable findings. The
initial surprise was that simply expressing hTERT in
primary cells led to telomerase activity [2,26,27]. Although
telomerase is composed of both protein and RNA, the
RNA component is often present even in cells that do not
normally have activity [28]. Apparently this level of RNA
is sufficient for telomerase activity when hTERT is
present. The next surprise was that the presence of
telomerase activity in primary cells was sufficient for
telomere elongation [1,2]. Although this was the result
that many had hoped for, recent evidence suggested that
the availability of telomere-binding proteins might limit
telomere growth [29]. At last the experiment could be
done: the frequency of senescent primary cell clones was
compared between cell that had telomerase activity and
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Figure 1
The telomere hypothesis of cell senescence and immortalization
proposes that: (1) Telomeres are maintained in the germline because
of the presence of telomerase. (2) Telomeres shorten due to the end
replication problem in many somatic cells that do not express
telomerase. (3) Agents such as oncogenes which extend cell life span
bypass the senescence signal. (4) Cultures containing cells with short
telomeres undergo a growth crisis where many cells die. (5) Immortal
cell clones that emerge from crisis have activated telomerase and so
maintain, or even lengthen, telomeres. 
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those that did not. Cells with longer telomeres did not
undergo senescence, whereas those with short telomeres
did [1,2]. Telomere length is therefore one criterion that
determines entry into cell senescence (Figure 2). 
The interpretation and the future
Like all good experiments, this discovery raises more ques-
tions than it answers. At the simplest level there are
detailed questions about how telomere length might signal
entry into senescence. What is measured? The length of
the shortest telomere? The average telomere length, or the
total number of telomere repeats? How is the signal sent
and what are the pathways that respond? The medical
implications of the experiment are also important to
explore. Extending the life span of primary cells could sig-
nificantly enhance the ability to grow cells ex vivo for autol-
ogous transplantation. This technique could be useful in
growing extra skin cells for burn victims, for example.
Telomerase has also been proposed for gene therapy to
extend the life span of cells in vivo [1]. Before such app-
roaches are implemented, it will be important to under-
stand better why cells senesce. If cellular senescence
indeed is a mechanism of tumor suppression (reviewed in
[6]), activation of telomerase might pre-dispose cells to
tumor formation by overcoming one of the many steps
required for transformation.
Recent experiments have shown that mouse cells lacking
telomerase become transformed and cause tumors [30].
Does this suggest that telomerase activation will not play a
role in the transformation of human cells? Probably not,
because there are important differences between human
and mouse cells. First the length of telomere repeat
sequence on mouse chromosomes is two-to-five times
longer than human telomere tracts [31–33], suggesting
mouse cells may be less sensitive than human cells to
telomere shortening. Second, mouse cells immortalize
much more readily than human cells. Humans, as a long-
lived species, may have evolved have additional mecha-
nisms to protect against cell immortalization and cancer.
Human cells may use telomeres to signal senescence and
thus limit cells growth, while mouse cells do not. With the
recent advances in understanding the basic structure and
synthesis of telomeres, it is now possible to test whether
extending cell life span might predispose human cells to
tumor formation.
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